Indian Pharmaceuticals & Biotech Stable Growth Stocks

Emcure Pharmaceuticals

Market Cap: ₹366.3b

Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.

Ajanta Pharma

Market Cap: ₹458.7b

A pharmaceutical formulation company engages in the development, manufacture, and marketing of specialty pharmaceutical finished dosages.

Neuland Laboratories

Market Cap: ₹299.1b

Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.

Acutaas Chemicals

Market Cap: ₹264.9b

Engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally.

Granules India

Market Cap: ₹212.6b

Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), finished dosages (FDs), and peptides CDMO in India and internationally.

Lupin

Market Cap: ₹1.0t

Operates as a pharmaceutical company in India, the United States, and internationally.

Ipca Laboratories

Market Cap: ₹440.0b

An integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India.

Sai Life Sciences

Market Cap: ₹307.5b

Operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally.

Aurobindo Pharma

Market Cap: ₹933.3b

A pharmaceutical company, develops, manufactures, and commercializes generic pharmaceuticals in India, the United States, Europe, and internationally.

Aether Industries

Market Cap: ₹215.7b

Produces and sells advanced intermediates and specialty chemicals in India and internationally.

Sun Pharmaceutical Industries

Market Cap: ₹4.6t

A generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally.

Rubicon Research

Market Cap: ₹268.0b

Operates as a specialty pharmaceutical company in India, the United States, and internationally.

Abbott India

Market Cap: ₹575.4b

Operates as a pharmaceutical company in India.

Anthem Biosciences

Market Cap: ₹501.3b

Operates as a contract research, development, and manufacturing organization in India, rest of Asia, North America, Europe, and internationally.

Biocon

Market Cap: ₹675.3b

Manufactures biotechnology products and offers research services in India, the United States, Ireland, rest of the European Union, and internationally.

GlaxoSmithKline Pharmaceuticals

Market Cap: ₹455.5b

Manufactures, distributes, and trades in pharmaceuticals in India and internationally.